Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.20.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]    
Net operating loss $ 14,060,172 $ 7,155,358
Non-deductible interest expense 357,021 247,938
Debt issue costs 285,114 426,817
Stock-based compensation expense 1,212,864 586,164
Patent licenses 13,886 15,826
Research and development tax credit carryforward 396,371 91,535
Accrued expenses 371,179 12,123
Section 195 deferred start-up costs 27,434 24,286
Deferred tax assets 16,724,041 8,560,047
Depreciation (16,407) (2,766)
Deferred Tax Liabilities (16,407) (2,766)
Deferred tax assets, net of deferred tax liabilities 16,707,634 8,557,281
Less: valuation allowance (16,707,634) (8,557,281)
Deferred tax assets, net after valuation allowance